Company Name: Replimune Group, Inc.

Replimune Group, Inc. is a clinical stage biotechnology company. The company is engaged in the development of oncolytic immunotherapies for cancer.

Ticker Symbol: REPL (NASDAQ)

Company Website: https://www.replimune.com

Social Media:

Replimune Twitter

Headquarters: Woburn, MA